Compounds > 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole

9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole and Morphine-Dependence

9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole has been researched along with Morphine-Dependence* in 1 studies

Other Studies

1 other study(ies) available for 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1-2-alpha)benzimidazole and Morphine-Dependence

ArticleYear
STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE.
    Eksperimental'naia i klinicheskaia farmakologiia, 2016, Volume: 79, Issue:4

    We have studied the physical dependence on and tolerance to the analgesic activity of compound RU-1205. It is established that this compound does not cause side effects typical of morphine and butorphanol including the development of withdrawal syndrome upon naloxone provocation and tolerance to analgesic activity upon 14-day administration.

    Topics: Analgesics; Analgesics, Opioid; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Drug Administration Schedule; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Morpholines; Naloxone; Narcotic Antagonists; Receptors, Opioid, mu; Substance Withdrawal Syndrome

2016